These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18332429)

  • 41. On enzymatic remodeling of IgG glycosylation; unique tools with broad applications.
    Sjögren J; Lood R; Nägeli A
    Glycobiology; 2020 Mar; 30(4):254-267. PubMed ID: 31616919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S; Crow AR; Freedman J; Lazarus AH
    Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A common glycan structure on immunoglobulin G for enhancement of effector functions.
    Lin CW; Tsai MH; Li ST; Tsai TI; Chu KC; Liu YC; Lai MY; Wu CY; Tseng YC; Shivatare SS; Wang CH; Chao P; Wang SY; Shih HW; Zeng YF; You TH; Liao JY; Tu YC; Lin YS; Chuang HY; Chen CL; Tsai CS; Huang CC; Lin NH; Ma C; Wu CY; Wong CH
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10611-6. PubMed ID: 26253764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel roles for the IgG Fc glycan.
    Anthony RM; Wermeling F; Ravetch JV
    Ann N Y Acad Sci; 2012 Apr; 1253():170-80. PubMed ID: 22288459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.
    Tong X; Li T; Orwenyo J; Toonstra C; Wang LX
    Bioorg Med Chem; 2018 Apr; 26(7):1347-1355. PubMed ID: 28789910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.
    Anthony RM; Nimmerjahn F; Ashline DJ; Reinhold VN; Paulson JC; Ravetch JV
    Science; 2008 Apr; 320(5874):373-6. PubMed ID: 18420934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgG Glyco-Engineering to Improve IVIg Potency.
    Bruggeman CW; Dekkers G; Visser R; Goes NWM; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
    Front Immunol; 2018; 9():2442. PubMed ID: 30405631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo.
    Biburger M; Aschermann S; Schwab I; Lux A; Albert H; Danzer H; Woigk M; Dudziak D; Nimmerjahn F
    Immunity; 2011 Dec; 35(6):932-44. PubMed ID: 22169040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
    Tremblay T; Paré I; Bazin R
    Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.
    Kurogochi M; Mori M; Osumi K; Tojino M; Sugawara S; Takashima S; Hirose Y; Tsukimura W; Mizuno M; Amano J; Matsuda A; Tomita M; Takayanagi A; Shoda S; Shirai T
    PLoS One; 2015; 10(7):e0132848. PubMed ID: 26200113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia.
    Nishimoto T; Satoh T; Takeuchi T; Ikeda Y; Kuwana M
    Exp Hematol; 2012 Apr; 40(4):279-89. PubMed ID: 22240606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fc gamma RI blockade and modulation for immunotherapy.
    Wallace PK; Keler T; Guyre PM; Fanger MW
    Cancer Immunol Immunother; 1997; 45(3-4):137-41. PubMed ID: 9435857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of idiotypic and antiidiotypic immunoglobulin G responses in an immune thrombocytopenic purpura patient as a consequence of extracorporeal protein A immunoadsorption.
    Balint JP; Cochran SK; Jones FR
    Artif Organs; 1995 Jun; 19(6):496-9. PubMed ID: 8526787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice.
    Dekkers G; Bentlage AEH; Plomp R; Visser R; Koeleman CAM; Beentjes A; Mok JY; van Esch WJE; Wuhrer M; Rispens T; Vidarsson G
    Mol Immunol; 2018 Feb; 94():54-60. PubMed ID: 29268168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.
    Lu J; Chu J; Zou Z; Hamacher NB; Rixon MW; Sun PD
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):833-8. PubMed ID: 25561553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes.
    Yang R; Otten MA; Hellmark T; Collin M; Björck L; Zhao MH; Daha MR; Segelmark M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2479-86. PubMed ID: 20219834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo effector functions of high-affinity mouse IgG receptor FcγRI in disease and therapy models.
    Gillis CM; Zenatti PP; Mancardi DA; Beutier H; Fiette L; Macdonald LE; Murphy AJ; Celli S; Bousso P; Jönsson F; Bruhns P
    J Autoimmun; 2017 Jun; 80():95-102. PubMed ID: 27745779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody.
    Pace D; Lewis N; Wu T; Gillespie R; Leiske D; Velayudhan J; Rohrbach A; Connell-Crowley L
    Biotechnol Prog; 2016 Sep; 32(5):1181-1192. PubMed ID: 27160519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Fc N-glycan sialylation on IgG structure.
    Zhang Z; Shah B; Richardson J
    MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
    Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
    Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.